The pathogens and harmless antigens from the bacterial flora and food constantly expose the mucosal surface of the gastrointestinal tract. The mucosal epithelial cells act not only as a physical barrier, but also as a local immune system, which plays a vital role in defense and self-tolerance. The gut mucosal immune system comprises several compartments: Peyer's patches and lymphoid follicles in the colonic mucosa, and lymphocytes in the lamina propria and intraepithelial lymphocytes. Peyer's patches mediate antigen uptake via specialized epithelial cells (M cells) and are rich in B cells for class switching into IgA-secreting cells. IgA secretion is one of the primary defenses against pathogens at mucosal surfaces. The lamina propria contains a high proportion of activated and memory T cells that allows rapid immune response against pathogens. In the physiological situation, mucosally encountered antigens induce tolerance of lamina propria and intraepithelial lymphocytes by modified antigen presentation, antigen-induced anergy, or deletion of T cells, or regulation of effector T cells by regulatory or suppressor T cells. Costimulatory molecules mediate cellular interaction and induce regulatory cytokines. While the absence of gut immune privilege to food results in food allergy, the consequences of immune privilege collapse to commensal gut flora is Inflammatory Bowel Disease (IBD). Hence, the knowledge of the homeostatic regulation of the intestinal immune system paves the way for the development of the new immunomodulatory drugs in the therapy of IBD. Moreover, the generation of immune mediated cells through orally fed antigens could be the area of research in the treatment of certain autoimmune diseases.
INTRODUCTION
The gastrointestinal tract has developed a unique immunological system because of its close proximity to the intestinal contents. The system has evolved in such a way that it does not respond to the presence of beneficial microbes, but retains the ability to react quickly to the presence of harmful organisms. The challenge faced by the mucosal immune system is to generate an immune response of appropriate magnitude to control the microbial invasion while maintaining the integrity of the epithelial barrier. An imbalanced or improper immune response can result in a variety of inflammatory disorders of the gut.
In normal conditions human gut mucosa is infiltrated with a large number of mononuclear cells due to continuous stimulation by luminal antigens. This state of "physiological" inflammation is tightly controlled, as several mucosal cells interact to maintain an appropriate local immune response. Moreover, gut-associated lymphoid tissue (GALT) must constantly distinguish harmless antigens that are present in food and on commensal bacteria from pathogenic microbes.
For better understanding of the mucosal immune response it is useful to divide the gut-associated lymphoid tissue into inductive and effector sites, although recent data indicate that these distinctions are not absolute.
The inductive site for the mucosal immune response
The primary inductive sites are organized lymphoid aggregates placed in the wall of the small and large intestine. In the small bowel these aggregates are called Peyer's patches 1 and are composed of specialized follicle-associated epithelium, a subepithelial dome overlying B cell follicles that contain germinal centers, and interfollicular regions with high endothelial venules and efferent lymphatic vessels. Isolated lymphoid follicles are also present in high numbers in the wall of the large bowel and the appendix. Following ingestion, antigens and micro-organisms are transported from the gut lumen via specialized M cells, which are scattered among conventional epithelial cells overlying the dome of Peyer's patch follicles. Compared with epithelial cells, with which they share a common progenitor cell, they have a pronounced capacity to transport a wide variety of substances and microbes to the subepithelial dome region. In the follicle such T cells provide help for the B cell switch to IgA, a process that is completed in the germinal center. IgA is the major mucosal immunoglobulin and can help to dispose of antigens without provoking the complement cascade. Following IgA switch and affinity maturation B cells migrate from the Peyer's patches to the mesenteric lymph node via efferent lymphatic vessels and finally to the lamina propria where they undergo terminal differentiation into plasma cells.
The question arises about the signals that make a B cell home to the gut and specifically produce IgA. It has been showed that the vitamin A metabolite retinoic acid produced by GALTderived dendritic cells confers gut tropism and, together with IL-6 or IL-5, induces IgA secretion. GALT-derived dendritic cells directly induce gut tropism in a retinoic-acid-dependent manner, and they induce class switching to IgA in B cells through a synergistic mechanism that also involves retinoic acid. This study is of clinical relevance as it might explain why vitamin A deficiency exacerbates diarrhoeal disease in malnourished children.
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The effector site for the mucosal immune response:
The 16 and the production of keratinocyte growth factor by IEL 17 suggest that some IEL populations play a role in maintenance of epithelial barrier integrity. In addition, TCRgdT cells may be involved in regulating the intestinal immune response. 18 In the lamina propria IgA antibodies secreted by plasma cells keep the homeostasis of the epithelium by interacting with antigen within the gut lumen after epithelial transcytosis or inside infected epithelial cells or by formation of immune complexes with antigen in the lamina propria. However, it is clear that the antibody response is highly dependent on T cell help. 19 This cell network in the mucosal immune system is highly integrated by the expression of specific costimulatory and adhesion molecules and the production of effector molecules such as cytokines.
Immune privilege in the gut:
The intestinal immune system constantly encounters foreign antigen, whether it be dietary antigen, components of the commensal gut flora, or antigens associated with pathogenic microbes. The gut falls squarely among those organs that can be considered immune privileged. There are two integral branches to immune privilege in the gut: oral tolerance and tolerance to commensal gut organisms.
20

Oral tolerance
Oral tolerance is defined as the induction of a state of systemic immune nonresponsiveness to orally administered antigen upon subsequent antigen challenge. This mechanism presumably prevents the development of an immune reaction or allergy against intestinal intraluminale antigens.
Most of data on oral tolerance have so far been obtained in the animal model of ovalbumin-TCR transgenic mice. T cells appear to be the major target of tolerance, and the reduction in antibody responses after antigen feeding are due to the reductions in helper activity rather than to a tolerization of B cells directly. The major mechanisms of tolerance induction are clonal deletion, clonal anergy, and the induction of suppressor cells. 21 IL-12, a Th1-directing cytokine, may be a key regulatory cytokine for these various pathways in the mucosal immune response. Factors that suppress IL-12 production by antigen-presenting cells result in suppressor or regulatory T cells (Tregs) producing TGF-b and possibly IL-4 and IL-10, while factors that induce IL-12 production result in T cells producing the proinflammatory cytokine interferon (IFN) g. [22] [23] [24] The nature and localization of the antigen-presenting cells responsible for tolerogenic presentation of fed antigens are unclear. T cell activation and/or deletion can be rapidly observed in the 31 The specificity and diversity of cytokine production and other effector functions downstream of TLR signaling result largely from differential recruitment of these adapter molecules. [33] [34] [35] For example, TLR4 has been shown to activate nuclear factor-kB (NF-kB) through the common MyD88 signaling pathway shared by all the TLRs except TLR3; however, TLR4 also uses a MyD88-independent TRIF signaling pathway, which has been shown to be critical for inducing costimulatory molecule expression in DCs and for optimal production at the messenger RNA level of the cytokines IL-12, IL-18, and IL-23. 35 Microbes that colonize intestinal mucus have metabolic and transcriptional profiles that differ from their biofilmindependent counterparts. 41, 42 Perhaps this altered profile facilitates host/microbial cross talk at the intestinal epithelial surface, promoting host tolerance to these microbes. Individual commensal gut microbes have been shown to reduce the production of proinflammatory cytokines by intestinal epithelial cells (IECs) by modulating the location and activity of enterocytic transcription factors such as NF-kB. [43] [44] [45] As the largest body surface to interact with the external environment, the intestinal epithelium (comprising IECs with tight junctions) serves as a barrier to unregulated transport and systemic dissemination of commensal and pathogenic microbes. 46 The physical epithelial barrier is reinforced with chemical components, including a glycocalyx formed by mucins bound to the apical surface of the IEC membrane and a sugarrich mucus layer secreted by goblet cells of the intestinal epithelium. This mucus layer is capable of trapping those microbes that lack mucinases, adherence, colonization, or invasion factors and restricting their ability to access the IECs. 46 Immunochemical members of the intestinal epithelial barrier include microbicidal peptides and proteins, such as defensins, 46 and the recently identified intestinal angiogenins. Commensal microbes are actually capable of inducing host production of these anti-microbial peptides. Current evidence also suggests that the commensal flora can induce sIgA with low affinity but with broad specificity to facilitate the sequestration of gut microbes to the luminal side of the gut epithelium. 47 The physical epithelial barrier is not absolute, however. Controlled transport of live microbes across the epithelial barrier is critical for the induction of adaptive immune effectors (B and T cells) with both protective and tolerant immune function.
Lamina propria dentritic cells have been shown to extend dendrites through the intestinal epithelium and into the lumen where they can sample antigen. IgA binding to commensal flora and luminal antigen facilitates adherence of these antigens to the M cells of Peyer's patches 48 and regulates transport of antigens across the epithelial barrier by M cells. 49 Recently, enterocytes themselves have been shown to phagocytose enteric microbes both in vitro and in vivo, thus mediating controlled translocation of these microbes across the intestinal epithelium. 50 It was demonstrated that intestinal epithelial cell lines expressing the innate immune receptor TLR4 were capable of phagocytosing the Gram negative bacterium E. coli in a TLR4-dependent fashion. 50 Such cross talk between antigen-experienced epithelial cells and gut-resident immune effector cells may be critical to the maintenance of immune tolerance to luminal contents.
Commensals that cross the epithelial layer are phagocytosed by macrophages resident in the gastrointestinal mucosa. They are efficiently destroyed by superoxide and inducible nitric oxide generation among other biocidal mechanisms. 51, 52 Moreover, Smythies et al. 53 have identified a population of human intestinal macrophages that neither express innate immune receptors, such as the lipopolysaccharide receptor CD14, nor produce proinflammatory cytokines, such as IL-1, IL-12, and TNF-a, in response to inflammatory microbial stimuli, in contrast to blood monocytes. Yet, while these intestinal macrophages exhibit 'inflammatory anergy', they are still fully capable of phagocytosis and bacteriocidal activity. 53 These characteristics make this population of intestinal macrophages ideal subepithelial sentinels. They can destroy luminal microbes with systemic inflammatory potential before these microbes interface with the systemic immune system without eliciting inflammatory changes in the gut that would upset gut homeostasis.
The restriction of commensal-bacteria bearing dendtritic cells to the mesentric lymph nodes can allow robust, local, protective mucosal immune responses to the gut flora (including sIgA production) in the absence of unneeded systemic immune responses. mesentric lymph nodes, thus, function as the center of immune privilege in the GALT.
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Tregs and tolerance to dietary and commensal antigens
Immunoquiescence to the gut commensal and dietary antigens is also facilitated by diverse immunoregulatory cells that actively suppress effector immune responses. Several different subsets of Tregs have been implicated in mucosal tolerance induction at the luminal/intestinal epithelial interface.
Intestinal epithelial and stromal-derived mediators promote the generation of immunoregulatory cells in the intestines; tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO)-mediated immunoregulation may be particularly relevant in the gut, as IECs constitutively express high levels of IDO. [55] [56] [57] Newberry et al. 58 demonstrated that non-bone marrow derived stromal cells in the intestinal lamina propria express basal levels of the enzyme cyclooxygenase 2 (COX2) and its arachidonic acid metabolite prostaglandin E2 (PGE2). As both COX2 and PGE2 have been shown to prevent inflammatory responses to dietary antigens, this finding implicated intestinal production of COX2 and its arachidonic acid metabolite in the modulation of the immune response to luminal intestinal antigens. 58 Other work has shown that enterocytes constitutively express thymic stromal lymphopoietin and preferentially induce 'noninflammatory' dendritic cells, which secrete IL-10 and IL-6 and induce Th responses that support the production of barrier protective mucosal IgA. 59 Smythies et al. 53 have reported that cellular components of the intestinal stroma, namely lamina propria mast cells, secrete TGF-b capable of driving blood monocytes to take on the phenotype of normal intestinal macrophages, inflammatory anergy, coupled with potent phagocytic and bacteriocidal activity in the face of a plethora of immunostimulatory commensal bacteria.
Immune privilege collapse in the gut:
Inflammatory bowel disease (IBD) and food allergy
In genetically predisposed individuals, breakdown in gut immune privilege can lead to disease at both ends of the Th1/ Th2 spectrum, as shown in the figure below. Food allergy, an adverse immune response to dietary proteins, affects 6-8% of children and 2-4% of adults and is characterized by gastrointestinal and extraintestinal symptoms and the production of large amounts of the Th2-dependent IgE. 60 Both clinical studies and animal models suggest that alterations in the intestinal microbiome (for example, a reduction in commensal flora or environmental floral burden secondary to increased hygiene, vaccination, and antibiotic use) or in microbiome signaling through TLRs predispose to food allergy. The pathogenesis of food allergy may also be linked to deficiencies in number and function of the CD4 + CD25 + Foxp3 + Treg cell compartment in genetically susceptible patients. [61] [62] [63] While the absence of gut immune privilege to food results in food allergy, the consequences of immune privilege collapse to commensal gut flora is IBD.
IBD comprises mainly ulcerative colitis (UC) and Crohn's disease (CD) characterized by long term intestinal inflammation attributable to an exaggerated immune response. 64 Earlier studies showed that in healthy humans, tolerance exists toward resident intestinal flora but is broken in active IBD. 65 This finding was recapitulated in a mouse model of experimental colitis in which health was restored by treatment with the immunoregulatory cytokine IL-10 or antibodies to the proinflammatory cytokine IL-12. 66 Ulcerative colitis (UC) is believed to encompass a heterogeneous group of diseases with different pathogenic mechanisms but common symptomatology. 67 Patients with UC experience contiguous inflammation of their colonic LP. 67 A spontaneously remitting and relapsing disorder, UC falls on the Th2 spectrum of intestinal disorders, as it is characterized by abnormally high amounts of the Th2 cytokines IL-4 and IL-13 produced by intestinal LP CD4 + T cells and natural killer (NK) T cells. 67 The pathogenesis of UC is largely unknown, although animal models of UC appear to be driven by dysregulated immune responses to commensal microflora with subsequent generation of cross-reactive autoantibodies. [68] [69] [70] [71] [72] Studies of Abreu et al. 73, 74 have implicated defects in TLR-mediated bacterial antigen sampling in the pathogenesis of the disease. Perhaps, a lack of microbially generated Tregs allows for inappropriate expansion of CD4 + Th2 and NK T-cell effector compartments, leading to excessive Th2 cytokine production and disease pathogenesis. 67 In contrast to UC, Crohn's disease is a Th1-dominant IBD; in patients with Crohn's disease, intestinal homeostasis is perturbed, and the production of inflammatory cytokines such as IFN-g and TNF-a is increased in the lamina propria. 75 The intestinal tract in Crohn's disease is characterized by patchy transmural inflammation. 75 Human studies suggest that primary defects in intestinal barrier function include altered mucus layer thickness 76, 77 and epithelial cell gene expression, 78 leading to increased permeability of the intestinal epithelium. 79 Increased intestinal permeability may facilitate barrier breach by commensal microbes and probable breakdown in systemic immunological ignorance to the commensal flora, contributing to disease pathogenesis. Lodes et al. 80 found elevated antiflagellin serum IgG levels in both Crohn's disease patients and mouse models of IBD, supporting the conclusion that bacterial flagellins are the dominant antigen in humans with Crohn's disease. Since TLR5 is only expressed on the basolateral surfaces of IECs, 81 83 have shown that colonization with helminth, which downregulates colitis in both human and animal models of IBD. 84 upregulated the expression of TLR4 on lamina propria T cells, thus promoting the production of lipopolysachharide-induced TGF-b but not proinflammatory cytokines. 83 In short, the addition of a helminth to an inflammatory intestinal environment may help restore the balance between commensal microbes and host, thus alleviating disease pathology.
CONCLUSION
The pathogens and harmless antigens from the bacterial flora and food constantly expose the mucosal surface of the gastrointestinal tract. The mucosal epithelial cells act not only as a physical barrier, but also as a local immune system, which plays a vital role in defense and self-tolerance. Dysregulation of this complex immune response can result in a collapse of immune privilege leading into chronic intestinal inflammation. Hence, the knowledge of the homeostatic regulation of the intestinal immune system paves the way for the development of the new immunomodulatory drugs in the therapy of IBD. Moreover, the generation of immune mediated cells through orally fed antigens could be the area of research in the treatment of certain autoimmune diseases. 
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